Agilent Technologies Inc vs iShares S&P GSCI Commodity-Indexed Trust ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares S&P GSCI Commodity-Indexed Trust ETF trades at $32.52. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares S&P GSCI Commodity-Indexed Trust ETF pays none. Which is the better fit depends on your goals.
| A | GSG | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $157.20 | $34.77 |
52-Week Low | $110.24 | $22.06 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
GSG trades at $31.09, up 0.06% on the day, with technical indicators showing a bearish trend from moving averages but neutral oscillators. Recent news highlights its energy-heavy commodity exposure driving past performance, though volatility and geopolitical risks have prompted a downgrade to Hold. Financial ratios are unavailable in the provided data.
The outlook is cautious due to sector volatility and reliance on energy markets. Risks include commodity price swings and geopolitical tensions, while potential upside hinges on sustained commodity strength. Investors should weigh the ETF's niche against broader market stability.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.
Read more on GSG →